(+/-)-beta-Phenylisopropylamine
Brand names,
(+/-)-beta-Phenylisopropylamine
Analogs
(+/-)-beta-Phenylisopropylamine
Brand Names Mixture
- Adderall (amphetamine + dextroamphetamine)
- Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
(+/-)-beta-Phenylisopropylamine
Chemical_Formula
C9H13N
(+/-)-beta-Phenylisopropylamine
RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
(+/-)-beta-Phenylisopropylamine
fda sheet
(+/-)-beta-Phenylisopropylamine
msds (material safety sheet)
(+/-)-beta-Phenylisopropylamine
Synthesis Reference
U. S. Pat. 1,879,003, (1932)
(+/-)-beta-Phenylisopropylamine
Molecular Weight
135.206 g/mol
(+/-)-beta-Phenylisopropylamine
Melting Point
Volatizes slowly at room temperature
(+/-)-beta-Phenylisopropylamine
H2O Solubility
Slightly
(+/-)-beta-Phenylisopropylamine
State
Solid
(+/-)-beta-Phenylisopropylamine
LogP
1.799
(+/-)-beta-Phenylisopropylamine
Dosage Forms
Capsules
(+/-)-beta-Phenylisopropylamine
Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
(+/-)-beta-Phenylisopropylamine
Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
(+/-)-beta-Phenylisopropylamine
Absorption
It forms easily absorbed molecules that are highly lipid soluble
(+/-)-beta-Phenylisopropylamine
side effects and Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
(+/-)-beta-Phenylisopropylamine
Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
(+/-)-beta-Phenylisopropylamine
Organisms Affected
Humans and other mammals